Super-vaccine trial for coronaviruses set for 2025

Health Policy Watch May 14, 2024, 05:00 PM UTC

Summary: Researchers have developed an all-in-one coronavirus vaccine to combat various strains, including unknown ones. Published in Nature Nanotechnology, the vaccine, tested successfully on mice, is set for human trials in early 2025. The vaccine's key component is a chain of receptor-binding-domains from different coronaviruses. This proactive vaccinology approach aims to swiftly respond to potential pandemics. The vaccine offers broad immunity, even against unanticipated coronaviruses.

Full article

Article metrics
Significance5.7
Scale9.0
Magnitude8.5
Novelty7.5
Actionability6.0
Immediacy4.0
Positivity7.0
Probability0.0
Credibility8.0

Timeline:

  1. [4.5]
    New vaccine tech targets multiple coronaviruses, shows promise (PMLiVE)
    20d
    Source
  2. [4.8]
    Oxford vaccine Quartet Nanocage targets 8 coronaviruses for protection (Mint)
    21d
    Source
  3. [5.4]
    Quartet nanocage vaccine targets coronavirus variants effectively (News-Medical.Net)
    21d

  4. [5.9]
    Scientists create universal coronavirus vaccine for future strains (The Guardian)
    23d